BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22394176)

  • 1. Reprogramming of B cells into regulatory cells with engineered fusokines.
    Deng J; Galipeau J
    Infect Disord Drug Targets; 2012 Jun; 12(3):248-54. PubMed ID: 22394176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo generation of murine IL-10-producing B cells by fusokines.
    Tormo A; Deng J; Al-Chami E; Ziouani S; Rafei M
    Methods Mol Biol; 2014; 1190():115-25. PubMed ID: 25015277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties.
    Rafei M; Hsieh J; Zehntner S; Li M; Forner K; Birman E; Boivin MN; Young YK; Perreault C; Galipeau J
    Nat Med; 2009 Sep; 15(9):1038-45. PubMed ID: 19668193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of B regulatory (B10) cells in inflammatory disorders and their potential as therapeutic targets.
    Wu H; Su Z; Barnie PA
    Int Immunopharmacol; 2020 Jan; 78():106111. PubMed ID: 31881524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell regulation in cancer and anti-tumor immunity.
    Sarvaria A; Madrigal JA; Saudemont A
    Cell Mol Immunol; 2017 Aug; 14(8):662-674. PubMed ID: 28626234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human B Regulatory Cells: The New Players in Autoimmune Disease.
    Maravillas-Montero JL; Acevedo-Ochoa E
    Rev Invest Clin; 2017; 69(5):243-246. PubMed ID: 29077695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.
    Matsushita T; Kobayashi T; Mizumaki K; Kano M; Sawada T; Tennichi M; Okamura A; Hamaguchi Y; Iwakura Y; Hasegawa M; Fujimoto M; Takehara K
    Sci Adv; 2018 Jul; 4(7):eaas9944. PubMed ID: 30009261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances of Regulatory B Cells in Autoimmune Diseases.
    Zhu Q; Rui K; Wang S; Tian J
    Front Immunol; 2021; 12():592914. PubMed ID: 33936028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory B1a Cells Suppress Melanoma Tumor Immunity via IL-10 Production and Inhibiting T Helper Type 1 Cytokine Production in Tumor-Infiltrating CD8
    Kobayashi T; Oishi K; Okamura A; Maeda S; Komuro A; Hamaguchi Y; Fujimoto M; Takehara K; Matsushita T
    J Invest Dermatol; 2019 Jul; 139(7):1535-1544.e1. PubMed ID: 30836062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GMCSF-interleukin fusion cytokines induce novel immune effectors that can serve as biopharmaceuticals for treatment of autoimmunity and cancer.
    Williams P; Galipeau J
    J Intern Med; 2011 Jan; 269(1):74-84. PubMed ID: 21158980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Progress on Regulatory B Cells in Systemic Lupus Erythematosus.
    Wang T; Mei Y; Li Z
    Biomed Res Int; 2019; 2019():7948687. PubMed ID: 31240224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex.
    Rafei M; Wu JH; Annabi B; Lejeune L; François M; Galipeau J
    Blood; 2007 Mar; 109(5):2234-42. PubMed ID: 17082320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APRIL Induces a Novel Subset of IgA
    Fehres CM; van Uden NO; Yeremenko NG; Fernandez L; Franco Salinas G; van Duivenvoorde LM; Huard B; Morel J; Spits H; Hahne M; Baeten DLP
    Front Immunol; 2019; 10():1368. PubMed ID: 31258536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.
    Aravena O; Ferrier A; Menon M; Mauri C; Aguillón JC; Soto L; Catalán D
    Arthritis Res Ther; 2017 Jan; 19(1):8. PubMed ID: 28103916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses.
    Maerz JK; Trostel C; Lange A; Parusel R; Michaelis L; Schäfer A; Yao H; Löw HC; Frick JS
    Front Immunol; 2019; 10():3093. PubMed ID: 32038631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 35 Regulatory B Cells.
    Choi JK; Egwuagu CE
    J Mol Biol; 2021 Jan; 433(1):166607. PubMed ID: 32755620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B10 cell regulation of health and disease.
    Candando KM; Lykken JM; Tedder TF
    Immunol Rev; 2014 May; 259(1):259-72. PubMed ID: 24712471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis.
    Kang M; Choi JK; Jittayasothorn Y; Egwuagu CE
    Front Immunol; 2020; 11():1051. PubMed ID: 32547555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory and effector B cells: Friends or foes?
    Matsushita T
    J Dermatol Sci; 2019 Jan; 93(1):2-7. PubMed ID: 30514664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune regulatory function of B cells.
    Mauri C; Bosma A
    Annu Rev Immunol; 2012; 30():221-41. PubMed ID: 22224776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.